Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
chronic migraine
3
×
clinical trials
eli lilly
fda
indiana blog main
indiana top stories
life sciences
national blog main
teva pharmaceutical
boston blog main
calcitonin gene-related peptide
episodic migraine
indiana
migraine research foundation
raleigh-durham blog main
raleigh-durham top stories
alder biopharmaceuticals
alprazolam
boston top stories
boulder/denver blog main
boulder/denver top stories
cgrp inhibitors
colucid pharmaceuticals
david rind
detroit blog main
detroit top stories
drug enforcement administration
drugs
eptinezumab
erenumab
food and drug administration
fremanezumab
galcanezumab
institute for clinical and economic review
lasmiditan
migraine
migraines
national
What
approval
drug
fda
migraine
new
3
×
won
class
developed
eli
lilly
medicines
pain
starts
acute
addresses
amgen
announced
approved
candidates
causes
condition
decades
decision
friday
gets
giant
giving
head
headache
lasmiditan
late
lilly’s
marks
medication
nod
oks
pharmaceutical
prevent
preventive
second
Language
unset
Current search:
won���t
×
new
×
" chronic migraine "
×
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines